Artabsin (Sesquiterpene Lactone · Bitter Tonic · Anthelmintic · Antimicrobial)
| Compound | Artabsin (Artabsine) |
| Chemical class | Terpenoid — Sesquiterpene Lactone (Guaianolide) |
| CAS | 546-43-0 |
| Primary source | Artemisia absinthium (wormwood), Artemisia annua (sweet wormwood) |
| Key applications | Anthelmintic, bitter tonic, antimicrobial, anti-inflammatory |
| Claim strength | Moderate |
| Typical form | Artemisia extract (artabsin as constituent); wormwood bitter tincture |
| Buy from Herbuno |
Name origin: From Artemisia absinthium (wormwood / absinthe plant), the species from which it was first isolated. Artabsin is a guaianolide-type sesquiterpene lactone — the primary bitter sesquiterpene of wormwood and a key contributor to the medicinal and organoleptic properties of Artemisia preparations. Traditional use: Wormwood (Artemisia absinthium) has been used for over 3,500 years as one of the most important medicinal plants in European, Arabic, and Persian traditions — used as an anthelmintic (anti-parasitic), digestive bitter, antimalarial (before artemisinin was isolated), and antimicrobial. Wormwood is the defining botanical of absinthe liqueur. In Ayurveda and Unani medicine, Artemisia species (including A. absinthium / Afsanteen) are used for worm infestations, liver conditions, and fever. Research trajectory: Artabsin contributes to wormwood’s bitter tonic activity (stimulating gastric acid and bile secretion via bitter taste receptors) and has documented antimicrobial, anti-inflammatory (NF-κB inhibition), and anthelmintic properties in preclinical research. Distinct from artemisinin (which is specific to A. annua) — artabsin is the principal sesquiterpene lactone of A. absinthium. Commercial source: Available as a constituent of Artemisia annua extract from the Herbuno catalogue. See sourcing options below.
Evidence for Artabsin Applications
Bitter tonic and digestive stimulant: Artabsin is one of the most intensely bitter natural compounds — detectable at parts-per-billion concentrations. It activates TAS2R (type 2 taste receptor) bitter taste receptors in the GI tract, stimulating gastric acid secretion, bile release, and pancreatic enzyme production. This cholagogue and stomachic effect is the traditional basis for wormwood bitters and European digestive liqueurs (Angostura, Campari). Claim strength: Moderate.
Anthelmintic: Artabsin and related sesquiterpene lactones demonstrate activity against intestinal helminths and protozoa in animal models. Historically, wormwood was the primary botanical anthelmintic in European medicine before pharmaceutical antiparasitics. Modern research supports anti-protozoal activity against Giardia, Trypanosoma, and Leishmania species. Claim strength: Moderate (preclinical; human antiparasitic data limited for artabsin specifically).
Anti-inflammatory: Artabsin inhibits NF-κB and reduces pro-inflammatory cytokine production in macrophage models. In vivo anti-inflammatory activity in rodent inflammatory models is documented. The α,β-unsaturated lactone Michael acceptor system is the likely pharmacophore for anti-inflammatory activity (similar to parthenolide in feverfew). Claim strength: Moderate.
Antimicrobial: Artabsin demonstrates activity against S. aureus, E. coli, Candida albicans, and Helicobacter pylori in vitro. Relevant for gut antimicrobial and oral health formulations. Claim strength: Moderate.
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Wormwood bitter preparations (traditional): 1–3 g dried herb equivalent per day as infusion or tincture. As a digestive bitter, artabsin is typically used at trace/flavour-level concentrations — its extreme bitterness means effective TAS2R stimulation occurs at very low doses (sub-milligram). Wormwood preparations are classified as traditional herbal medicines in the EU (THMPD status) for digestive complaints. IMPORTANT: Wormwood contains thujone (a neurotoxic monoterpene) alongside artabsin — high-dose or chronic use of whole wormwood preparations is associated with thujone-related CNS toxicity. Artabsin-standardised extracts or low-thujone wormwood preparations are preferred for supplement use. The EU limits thujone in food-grade wormwood preparations to 10 ppm.
Frequently Asked Questions — Artabsin
Is artabsin the same as artemisinin?
No — they are entirely different compounds from related but distinct Artemisia species. Artabsin is a guaianolide sesquiterpene lactone primarily from Artemisia absinthium (wormwood) with bitter tonic and anthelmintic properties. Artemisinin is a sesquiterpene endoperoxide lactone specific to Artemisia annua (sweet wormwood) and is the basis of the most effective malaria treatment. They share a sesquiterpene lactone scaffold but have completely different mechanisms, botanical sources, and clinical applications.
What is the thujone concern with wormwood?
Thujone is a neurotoxic monoterpene (GABA-A receptor antagonist) present in Artemisia absinthium and responsible for historical concerns about absinthe-related neurological effects. The thujone content of traditional absinthe was exaggerated historically; modern analysis shows historical absinthe contained less thujone than often claimed. Nonetheless, thujone limits in food products are regulated in the EU and US. For supplement use, specify low-thujone wormwood extract (<10 ppm thujone) and verify by GC analysis alongside artabsin content.
Can wormwood be used as a natural digestive bitter?
Yes — wormwood is one of the most established botanical digestive bitters in European phytomedicine. The ESCOP and German Commission E monographs support wormwood for loss of appetite, dyspepsia, and biliary dyskinesia. Artabsin is the primary bitter principle driving these effects. For digestive bitter formulations, wormwood can be combined with gentian (gentiopicrin), dandelion root (sesquiterpene lactones), and centaury (secoiridoids) for a synergistic multi-botanical bitter blend.
Is artabsin safe for long-term use?
Short-term use (up to 4 weeks) of wormwood preparations at recommended doses is considered safe in EU phytomedicine frameworks. Long-term use is not recommended due to potential thujone accumulation and CNS effects at higher doses. Contraindicated in pregnancy (uterotonic/abortifacient potential at high doses — traditional use for this purpose is documented and is a contraindication for modern supplement use). Standard contraindications for bile duct obstruction and peptic ulcer apply for high-dose bitter preparations.
Related compounds: Artemisinin, Thymoquinone, Bisabolol, Guaiol
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery